Nutshell's platform combines AI and big data to create a biomedical and chemical data platform for drug research, providing drug developers and research labs with a high-performing medical research platform. The company focuses on inventing small molecules that target specific protein families in cancer, particularly in cases of colon, breast, and prostate cancer. These molecules are currently in the pre-clinical stage, with the aim of advancing drug discovery through protein dynamics.